KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹169 Cr | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr |
What is the latest Total Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹178 Cr |
| Mar2023 | ₹175 Cr |
| Mar2022 | ₹190 Cr |
| Mar2021 | ₹159 Cr |
How is Total Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹169 Cr | -5.13 | |
| Mar2024 | ₹178 Cr | 1.82 | |
| Mar2023 | ₹175 Cr | -7.81 | |
| Mar2022 | ₹190 Cr | 19.21 | |
| Mar2021 | ₹159 Cr | - | |
Compare Total Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹147.1 Cr | -4.3% | -1.2% | -42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -4.3% |
-1.2% |
-42.4% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses